Insys Therapeutics ROE 2006-2018 | INSY

Current and historical return on equity (ROE) values for Insys Therapeutics (INSY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Insys Therapeutics ROE for the three months ending December 31, 2018 was -1430.52%.
Insys Therapeutics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $-0.12B $-0.04B -1696.55%
2018-09-30 $-0.12B $0.00B -356.52%
2018-06-30 $-0.26B $0.03B -424.59%
2018-03-31 $-0.24B $0.05B -197.94%
2017-12-31 $-0.23B $0.07B -128.61%
2017-09-30 $-0.18B $0.11B -80.88%
2017-06-30 $-0.02B $0.27B -5.58%
2017-03-31 $-0.00B $0.27B -0.37%
2016-12-31 $0.01B $0.27B 3.06%
2016-09-30 $0.03B $0.27B 11.28%
2016-06-30 $0.05B $0.26B 20.61%
2016-03-31 $0.05B $0.25B 23.15%
2015-12-31 $0.06B $0.25B 26.79%
2015-09-30 $0.05B $0.23B 24.10%
2015-06-30 $0.03B $0.20B 19.65%
2015-03-31 $0.03B $0.18B 22.19%
2014-12-31 $0.04B $0.17B 27.17%
2014-09-30 $0.05B $0.15B 47.86%
2014-06-30 $0.05B $0.12B 61.27%
2014-03-31 $0.05B $0.10B 75.97%
2013-12-31 $0.04B $0.08B 167.35%
2013-09-30 $0.01B $0.05B -86.96%
2013-06-30 $-0.01B $0.03B 25.53%
2013-03-31 $-0.02B $-0.06B 53.13%
2012-12-31 $-0.02B $-0.07B 110.77%
2012-09-30 $-0.01B $0.00B 102.33%
2012-06-30 $-0.01B $0.00B 74.42%
2012-03-31 $-0.00B $0.00B 27.91%
2011-12-31 $-0.00B $-0.04B 41.03%
2010-06-30 $-0.01B $0.00B -600.00%
2010-03-31 $-0.01B $0.00B -254.55%
2009-12-31 $-0.01B $0.00B -290.91%
2009-09-30 $-0.01B $0.00B -177.78%
2009-06-30 $-0.01B $0.01B -110.34%
2009-03-31 $-0.01B $0.00B -88.89%
2008-12-31 $-0.01B $0.01B -61.54%
2008-09-30 $-0.01B $0.01B -47.46%
2008-06-30 $-0.01B $0.01B -35.82%
2008-03-31 $-0.01B $0.02B -43.84%
2007-12-31 $-0.01B $0.02B -54.32%
2007-09-30 $-0.02B $0.02B -78.26%
2007-06-30 $-0.03B $0.02B -91.74%
2007-03-31 $-0.03B $0.02B -93.94%
2006-12-31 $-0.03B $0.03B -85.00%
2006-09-30 $-0.04B $0.04B -94.12%
2006-06-30 $-0.04B $0.04B -105.41%
2006-03-31 $-0.04B $0.05B -101.37%
2005-12-31 $-0.04B $0.02B -112.68%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.328B $0.082B
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29